Immucor’s patented Capture solid phase technology is an efficient and flexible antibody screening and identification technology with proven results. Our solid phase technology is so reliable, Capture-R^® Ready-Screen^® is the method of choice for screening over 90% of the North American blood supply and is utilized in renowned blood donor centers globally. With a full line of assays and innovative instrumentation to facilitate and automate the test process, Capture becomes the only logical choice for taking your laboratory to the next level of productivity.

Accuracy    

• IgG specific technology detects clinically significant antibodies
• Sensitivity and specificity are higher than manual tube or gel test methods
• Objective reaction end points eliminate subjectivity
• Capture LISS additive changes color assuring sample addition
  

• Pre-coated antibody screen and identification cells, no liquid cells to manage
• No pre-dilution of reagents or precision pipetting required, less hands-on time
• Same methodology and procedures for all assays, simplifies training
  

• Run a single sample or a full batch
• Manual, semi-automated and fully automated Scalable Solutions, Echo^® or NEO^®
• Wide range of assays utilize same test platform